{"id":1336,"date":"2023-05-30T14:00:06","date_gmt":"2023-05-30T14:00:06","guid":{"rendered":"https:\/\/fhucare2.laurent-angeli.fr\/event\/ag-fhu-care\/"},"modified":"2025-12-25T19:00:48","modified_gmt":"2025-12-25T18:00:48","slug":"ag-fhu-care","status":"publish","type":"post","link":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/event\/ag-fhu-care\/","title":{"rendered":"AG FHU CARE"},"content":{"rendered":"<p style=\"text-align: center\"><span style=\"font-size: 10pt\">PROGRAMME AG FHU CARE<br \/>Lundi 19 juin 2023&nbsp;(14h-17h)<br \/>Bic\u00eatre, nouveau b\u00e2timent recherche de la Facult\u00e9 de M\u00e9decine UPSaclay, salle 1&nbsp;<br \/><\/span><\/p>\n<p><span style=\"color: #333399;font-size: 10pt\"><strong><strong>14.00&nbsp;:&nbsp;<\/strong>Introduction<\/strong> et <strong>avancements<\/strong> <strong>DIM ITAC <\/strong>par <strong>Xavier Mariette&nbsp;<\/strong><\/span><\/p>\n<p><a href=\"en\/work-packages\/auto-immunity-and-inflammation-are-risk-factors-of-cancer\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #333399;font-size: 10pt\"><strong>WP2: Auto immunity as a risk factor of Cancer&nbsp;<\/strong><\/span><\/a><\/p>\n<ul>\n<li><span style=\"font-size: 10pt\">Pr\u00e9sentation du travail sur suivi clinique lymphome MALT Sjogren et effet de l\u2019immuno-chimio sur la r\u00e9duction du risque de rechute du Sj\u00f6gren par <strong>Ga\u00e9tane Nocturne<\/strong>&nbsp;<\/span><\/li>\n<\/ul>\n<p><a href=\"en\/work-packages\/immune-related-adverse-events-iraes-in-the-immunotherapy-of-cancer\"><span style=\"color: #333399;font-size: 10pt\"><strong>WP3: Risk of Autoimmunity after ICI&nbsp;<\/strong><\/span><\/a><\/p>\n<ul>\n<li><span style=\"font-size: 10pt\">Update donn\u00e9es PREMIS par <strong>Siham Farhane<\/strong><\/span><\/li>\n<li><span style=\"font-size: 10pt\">PHRC Picasso par <strong>Franck Carbonnel<\/strong>&nbsp;<\/span><\/li>\n<li><span style=\"font-size: 10pt\">Travaux cliniques sur les toxicit\u00e9s par <strong>Olivier Lambotte&nbsp;<\/strong><\/span><\/li>\n<li><span style=\"font-size: 10pt\">Projet de collaboration avec <strong>Dana Farber<\/strong> par <strong>Fran\u00e7ois-Xavier Danlos<\/strong><\/span><\/li>\n<li><span style=\"font-size: 10pt\">Point dans les analyses des r\u00e9ponses humorales (HuProt) via la collab avec <strong>CDI Labs<\/strong> par <strong>Aur\u00e9lien Marabelle<\/strong><\/span><\/li>\n<\/ul>\n<p><em><span style=\"font-size: 10pt\">Coffee break<\/span><\/em><\/p>\n<p><a href=\"en\/work-packages\/common-pathways-involved-in-autoimmune-diseases-cancer-and-inflammatory-diseases\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #333399;font-size: 10pt\"><strong>WP1: Common and opposite mechanisms involved in AID and cancer<\/strong><\/span><\/a><\/p>\n<ul>\n<li><span style=\"font-size: 10pt\">CDKN1A is a target for phagocytosis-mediated cellular immunotherapy in acute leukemia &#8211; Nature Communications par <strong>Jean-Luc Perfettini<\/strong><\/span><\/li>\n<li><span style=\"font-size: 10pt\">Le nouveau score des IrAE de <strong>Andy Cope<\/strong> par <strong>Xavier Mariette<\/strong><\/span><\/li>\n<li><span style=\"font-size: 10pt\">Avanc\u00e9es de <strong>Lo\u00efc Meudec<\/strong> sur les organo\u00efdes dans l\u2019optique de la poursuite de la collaboration avec <strong>Fanny Jaulin<\/strong> sur immuno- organo\u00efdes et pr\u00e9visions immunotox&nbsp;par <strong>Ga\u00e9tane Nocturne&nbsp;<\/strong><\/span><\/li>\n<li><span style=\"font-size: 10pt\">Anti TNF et SENESCENCE dans les maladies auto immunes par <strong>Nathalie Chaput-Gras<\/strong>, <strong>Ga\u00e9tane Nocturne<\/strong>, <strong>Marie Naigeon<\/strong> et<strong> Samuel Bitoun<\/strong>&nbsp;<\/span><\/li>\n<li><span style=\"font-size: 10pt\">Anticorps anti m\u00e9dicaments dans MAI et le cancer&nbsp;: ABIRA et phagocytose par <strong>Samuel Bitoun<\/strong>&nbsp;<\/span><\/li>\n<\/ul>\n<p><a href=\"en\/work-packages\/teaching-the-relation-between-auto-immunity-and-cancer\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #333399;font-size: 10pt\"><strong>&nbsp;WP4&nbsp;: Education<\/strong><\/span><\/a><\/p>\n<ul>\n<li><span style=\"font-size: 10pt\"><strong>E-learning<\/strong> : SPOC EUGLOH MIRACIP, lancement de la 2nde \u00e9dition : <a href=\"en\/work-packages\/teaching-the-relation-between-auto-immunity-and-cancer\" target=\"_blank\" rel=\"noopener\"><strong>Management of immunorelated complication of cancer immunotherapy<\/strong><\/a> par <strong>Olivier Lambotte<\/strong>&nbsp;<\/span><\/li>\n<\/ul>\n<p><span style=\"font-size: 10pt\"><strong>17.00&nbsp;: FIN de l\u2019AG FHU CARE.<\/strong><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PROGRAMME AG FHU CARELundi 19 juin 2023&nbsp;(14h-17h)Bic\u00eatre, nouveau b\u00e2timent recherche de la Facult\u00e9 de M\u00e9decine UPSaclay, salle 1&nbsp; 14.00&nbsp;:&nbsp;Introduction et avancements DIM ITAC par Xavier Mariette&nbsp; WP2: Auto immunity as a risk factor of Cancer&nbsp; Pr\u00e9sentation du travail sur suivi clinique lymphome MALT Sjogren et effet de l\u2019immuno-chimio sur la r\u00e9duction du risque de rechute [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1337,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"event_date":"Lundi 19 juin 2023","event_location":"Bic\u00eatre, nouveau b\u00e2timent recherche - salle 1","event_time":"de 14h00 \u00e0 17h00","footnotes":""},"categories":[10],"tags":[],"class_list":["post-1336","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-event"],"_links":{"self":[{"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/posts\/1336","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/comments?post=1336"}],"version-history":[{"count":2,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/posts\/1336\/revisions"}],"predecessor-version":[{"id":2412,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/posts\/1336\/revisions\/2412"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/media\/1337"}],"wp:attachment":[{"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/media?parent=1336"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/categories?post=1336"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fhucare2.laurent-angeli.fr\/fr\/wp-json\/wp\/v2\/tags?post=1336"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}